Lin Yan-Ting, Chen Wei-Ting, Wu Tsung-Han, Liu Yu, Liu Li-Tong, Teng Wei, Hsieh Yi-Chung, Wu Yen-Mu, Huang Chien-Hao, Hsu Chao-Wei, Chien Rong-Nan
Department of Hepatology, Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital, Linkou Medical Center, Taoyuan 33305, Taiwan.
College of Medicine, Chang-Gung University, Taoyuan 33302, Taiwan.
Diagnostics (Basel). 2023 Aug 2;13(15):2578. doi: 10.3390/diagnostics13152578.
Spontaneous bacterial peritonitis (SBP) is a severe complication in cirrhosis patients with ascites, leading to high mortality rates if not promptly treated. However, specific prediction models for SBP are lacking.
This study aimed to compare commonly used cirrhotic prediction models (CTP score, MELD, MELD-Na, iMELD, and MELD 3.0) for short-term mortality prediction and develop a novel model to improve mortality prediction.
Patients with the first episode of SBP were included. Prognostic values for mortality were assessed using AUROC analysis. A novel prediction model was developed and validated.
In total, 327 SBP patients were analyzed, with HBV infection as the main etiologies. MELD 3.0 demonstrated the highest AUROC among the traditional models. The novel model, incorporating HRS, exhibited superior predictive accuracy for in-hospital in all patients and 3-month mortality in HBV-cirrhosis, with AUROC values of 0.827 and 0.813 respectively, surpassing 0.8.
MELD 3.0 score outperformed the CTP score and showed a non-significant improvement compared to other MELD-based scores, while the novel SBP model demonstrated impressive accuracy. Internal validation and an HBV-related cirrhosis subgroup sensitivity analysis supported these findings, highlighting the need for a specific prognostic model for SBP and the importance of preventing HRS development to improve SBP prognosis.
自发性细菌性腹膜炎(SBP)是肝硬化腹水患者的一种严重并发症,若不及时治疗会导致高死亡率。然而,目前缺乏SBP的特异性预测模型。
本研究旨在比较常用的肝硬化预测模型(CTP评分、MELD、MELD-Na、iMELD和MELD 3.0)对短期死亡率的预测情况,并开发一种新模型以改善死亡率预测。
纳入首次发生SBP的患者。使用受试者工作特征曲线下面积(AUROC)分析评估死亡率的预后价值。开发并验证了一种新的预测模型。
共分析了327例SBP患者,主要病因是乙肝病毒(HBV)感染。在传统模型中,MELD 3.0的AUROC最高。纳入肝肾综合征(HRS)的新模型对所有患者的院内死亡率以及HBV肝硬化患者的3个月死亡率均表现出卓越的预测准确性,AUROC值分别为0.827和0.813,均超过0.8。
MELD 3.0评分优于CTP评分,与其他基于MELD的评分相比有不显著的改善,而新的SBP模型显示出令人印象深刻的准确性。内部验证和HBV相关肝硬化亚组敏感性分析支持了这些发现,凸显了需要针对SBP建立特异性预后模型以及预防HRS发生对改善SBP预后的重要性。